Beck Bode’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
Beck Bode's PTCT Position: Q3 2026 in Review
Beck Bode increased its PTC Therapeutics (PTCT) stake by 8.7% in Q3 2026, buying an estimated $25.5K and bringing the position to 4,374 shares worth $283K. The position accounts for 0.04% of the portfolio, ranked #81.
Beck Bode first reported a position in PTCT in Q2 2026 and has held it in 2 quarters since. The position peaked at $328K in Q2 2026. 275 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- Beck Bode held 4,374 shares of PTC Therapeutics worth $283K as of Q3 2026.
- Beck Bode bought 350 PTC Therapeutics shares in Q3 2026, an estimated $25.5K.
- PTC Therapeutics made up 0.04% of Beck Bode's portfolio in Q3 2026, its #81 holding.
- Beck Bode first reported a position in PTC Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Beck Bode's PTC Therapeutics position peaked at $328K in Q2 2026.
- 275 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.